GlassScriptPhysician profile
Lori Bratetic
NPI 1770258097
$793.98
in general payments reported to CMS, 2019-2025
11 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $67.10 · 2024: $491 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $158.71 | 2024-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $134.49 | 2023-2025 | Austedo Xr, Uzedy, Austedo |
| Alkermes, INC. | $122.86 | 2023-2025 | Aristada, Lybalvi |
| Vanda Pharmaceuticals INC. | $105.40 | 2024-2025 | Hetlioz, Fanapt |
| Abbvie INC. | $73.61 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $71.02 | 2024-2025 | Ingrezza |
| Noven Therapeutics, LLC | $44.62 | 2024-2025 | Secuado, Xelstrym |
| Janssen Pharmaceuticals, INC | $32.59 | 2024 | Invega Sustenna |
| Corium, LLC | $20.44 | 2024-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $17.45 | 2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $12.79 | 2023 | Abilify Maintena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Bratetic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.